FDA Approves Miami Cancer Institute to Perform New In-house Test for COVID-19 in Its Molecular Diagnostic Lab
The Food & Drug Administration granted Emergency Use Authorization (EUA) for Baptist Hospital of Miami Molecular Diagnostic Laboratory at Miami Cancer Institute, to perform a new COVID-19 swab tests in-house. The test was...
Read More















